PBIO Continues to Update Shareholders as Data from the Analysis of Cancer Tissue Proteins Generated from Novel Workflow Could Lead to Improvement in the Clinical Management of Gynecological Cancers; Pressure BioSciences’ Proprietary PCT Platform Fills Pivotal Role for Tumor Analyses in Novel Workflow Presented at Leading Global Gynecologic Cancer Meeting https://finance.yahoo.com/news/pressure-biosciences-proprietary-pct-platform-113000015.html